Two recent outbreak investigations in the USA
found that the risk of mumps increased with time
elapsed since vaccination, suggesting possible waning
of vaccine-induced immunity (45, 46). Few studies
of Jeryl Lynn vaccine have been conducted in
developing countries; however, in the Dominican
Republic, a study of this vaccine reported 94%
seroconversion among 72 seronegative children aged
1–6 years (47).